Mitomycin-C in combination with fluoropyrimidines in the treatment of metastatic colorectal cancer after oxaliplatin and irinotecan failure


ALKIS N., Demirci U., Benekli M., Yilmaz U., Isikdogan A., Sevinc A., et al.

JOURNAL OF BUON, cilt.16, ss.80-83, 2011

  • Cilt numarası: 16 Konu: 1
  • Basım Tarihi: 2011
  • Dergi Adı: JOURNAL OF BUON
  • Sayfa Sayısı: ss.80-83

Özet

Purpose: To retrospectively evaluate the efficacy and tolerability of mitomycin-C (MMC) in combination with fluoropyrimidines as salvage 3rd -or 4th-line therapy in metastatic colorectal cancer (MCRC) patients.